Journals / Turkish Journal of Endocrinology and Metabolism / 2016 / Cilt: 20 - Sayı: 3

Uluslararası Diyabet Tedavi Pratikleri Kayıt Çalışması - Türkiye 5. Dönem Sonuçları

The International Diabetes Management Practices Study (IDMPS) - Turkey's 5th Wave Results

Pages
88–96
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Diabetes patient education aiming to provide the knowledge necessary to make and maintain lifestyle changes is necessary.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing in Turkey due to rising obesity rates, sedentary life styles and Turkey's aging population; up-to-date and standardized data collection is required for the global fight against diabetes.
📊
Key Findings & Data:The data collected from Turkey during the 5th wave of a multinational, multi-center and observational study are evaluated in this article.Material and Method: The International Diabetes Management Practices Study (IDMPS) which is an international, observational multicenter, cross-sectional study, evaluated demographic and clinical characteristics of diabetic patients, treatment modalities, complications, cardiovascular risk factors and also reported the results of the patient health questionnaire (PHQ-9).Results: This study consisted of 842 T2DM and 115 Type 1 diabetes mellitus (T1DM) patients and was carried out by 94 doctors in Turkey between December 13th 2011 and January 26th 2012.
💡
Conclusion & Impact:Diabetes patient education aiming to provide the knowledge necessary to make and maintain lifestyle changes is necessary.
🔬Design:Survey & Empirical Study
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing in Turkey due to rising obesity rates, sedentary life styles and Turkey's aging population; up-to-date and standardized data collection is required for the global fight against diabetes. The data collected from Turkey during the 5th wave of a multinational, multi-center and observational study are evaluated in this article.Material and Method: The International Diabetes Management Practices Study (IDMPS) which is an international, observational multicenter, cross-sectional study, evaluated demographic and clinical characteristics of diabetic patients, treatment modalities, complications, cardiovascular risk factors and also reported the results of the patient health questionnaire (PHQ-9).Results: This study consisted of 842 T2DM and 115 Type 1 diabetes mellitus (T1DM) patients and was carried out by 94 doctors in Turkey between December 13th 2011 and January 26th 2012. Data revealed that 52% of patients were treated with oral anti-diabetic (OAD) drugs only, 29% were treated with OAD + insulin, and 18% of subjects were treated with insulin alone. 88% of T2DM patients had at least one microvascular complication and 99% had at least one cardiovascular risk factor. Only 27% of T1DM and 28% of T2DM patients reached the target hemoglobin A1c value of <7%. PHQ-9 results revealed that majority of patients did not have a depressive disorder (79% for both T1DM and T2DM).Discussion: Attainment and maintenance of the internationally recommended optimal glycemic values is essential for effective treatment of diabetes. Almost 72% of T2DM patients in Turkey did not reach the target values. Diabetes patient education aiming to provide the knowledge necessary to make and maintain lifestyle changes is necessary.

Özet

Amaç: Obezite, hareketsiz yaşam tarzı ve yaşlanan popülasyon Türkiye'de tip 2 diyabeti (T2DM) arttırmaktadır ve diyabete karşı savaş için güncel ve standardize edilmiş bilgilere ihtiyaç vardır. Bu yazıda uluslarası, çok merkezli gözlemsel bir çalışmanın Türkiye'ye ait beşinci dönem sonuçları değerlendirilmiştir. Gereç ve Yöntem: Bu çalışma diyabet hasta profili, tedavi seçenekleri, komplikasyonlar, kardiovasküler risk faktörleri, ayrıca hastaların sağlık anketi (PHQ-9) sonuçlarının değerlendirildiği kesitsel bir çalışma olarak yürütülmüştür. Bulgular: Bu çalışma Türkiye'de 13 Aralık 2011 ve 26 Ocak 2012 tarihleri arasında 94 araştırmacı tarafından yürütülmüş ve çalışmaya 842 T2DM, 115 tip 1 diyabet (T1DM) hastası alınmıştır. Hastaların %52'si oral anti diyabetik ajan (OAD), %29'u OAD + insülin, %18'i ise sadece insülin tedavisi almıştır. Hastaların %88'inde en az bir mikrovasküler komplikasyon ve %99'unda en az bir kardiyovasküler risk faktörü tespit edilmiştir. T1DM hastaların sadece %27'si, T2DM hastaların ise sadece %28'i, <%7 olan hedef hemoglobin A1c seviyesine ulaşabilmiştir. PHQ-9 sonuçları hastaların çoğunluğunun (T1DM ve T2DM için %79) depresif olmadığını göstermiştir. Tartışma: Önerilen optimal glisemik değerlere ulaşılması ve korunması etkili diyabet tedavisi için şarttır. Türkiye'de T2DM hastalarının neredeyse %72'si bu hedeflere ulaşamamaktadır. Hastaların diyabet eğitimine ve yaşam tarzında değişiklik yapmalarına ihtiyaç vardır.

🔖

Cite This Article

İLKOVA, H., DAMCI, T., KARŞIDAĞ, K., ÇÖMLEKÇİ, A., AYVAZ, G. (2016). Uluslararası Diyabet Tedavi Pratikleri Kayıt Çalışması - Türkiye 5. Dönem Sonuçları. Turkish Journal of Endocrinology and Metabolism, Cilt: 20 - Sayı: 3, 88–96. https://ajindex.com/articles/370799

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. IDF Diabetes Atlas seventh edition. IDF, Bruxelles, 2016. https://www.idf.org/ sites/default/files/EN_7E_Atlas_Full_0.pdf Accessed on 12.03.2016 Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003;29:6S9-6S18. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787. International Diabetes Federation website.Accessed on 14.01.2014 http:// www.idf.org/worlddiabetesday/toolkit/gp/facts-figures Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405. Williams R. Medical and economic case for prevention of type 2 diabetes and cardiovascular disease. Eur Heart J Suppl 2005;7(Suppl D):14-17. He effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.
  2. ADA (2003) "Clinical Practice Recommendations 2003." Diabetes Care 26: Suppl 1. Mottur-Pilson C, Snow V, Bartlett K. Physician explanations for failing to comply with "best practices". Eff Clin Pract 2001;4:207-213.
  3. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework of improvement. JAMA 1999;282:1458-1465. Geographic patters of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group. Diabetes 1998;37:1113-1119.
  4. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744.
  5. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, Bastar I, Tütüncü Y, Sargin M, Dinççag N, Karsidag K,Kalaça S, Ozcan C, King H. Population- based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP)). Diabetes Care 2002;25:1551- 1556. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediab